0000874015-24-000239.txt : 20241114 0000874015-24-000239.hdr.sgml : 20241114 20241114173042 ACCESSION NUMBER: 0000874015-24-000239 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241112 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOSCALZO JOSEPH CENTRAL INDEX KEY: 0001276128 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 241464587 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-11-12 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001276128 LOSCALZO JOSEPH 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 1 Common Stock 2024-11-12 4 S 0 13508 37.861 D 32251 D Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.62 to $38.595 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4. By: Patrick R. O'Neil, attorney-in-fact For: Joseph Loscalzo 2024-11-13